Furthermore, the INS/IGF-1 signaling pathway shows the most significant part in the evolution of insulin resistance (IR) by modifying the glucose breakdown of peripheral tissue, yet the Inhibition of GSK-3β in the liver is the main target to promote the utilization of glucose and improve insulin resistance. This evidence concerns the gene IGF1 and Insulin resistance.